(Q43803507)

27 November 2017

title

Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine (English)

1 reference

27 November 2017

White R

1

1 reference

27 November 2017

Alcorn R

series ordinal

2

1 reference

27 November 2017

Feinmann C

series ordinal

3

1 reference

27 November 2017

publication date

1 December 2001

1 reference

Drug and Alcohol Dependence

27 November 2017

published in

1 reference

27 November 2017

volume

65

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

77-83

1 reference

The use of lofexidine by drug dependency units in the United Kingdom

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

A naturalistic study of home detoxification from opiates using lofexidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Outpatient opiate detoxification treatment with buprenorphine. Preliminary investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

The development of a Short Opiate Withdrawal Scale (SOWS)

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Self-detoxification by opiate addicts. A preliminary investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Emergence of buprenorphine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Methadone maintenance to abstinence. How many make it?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Buprenorphine in opiate withdrawal: a comparison with clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Three methods of opioid detoxification in a primary care setting. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

The influence of psychological factors on the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Audit of the in-patient management of opioid withdrawal using lofexidine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900149-1

7 January 2021

10.1016/S0376-8716(01)00149-1

Identifiers

DOI

1 reference

27 November 2017

1 reference